Ferroptosis and traumatic brain injury

Area of Science:

• Neuroscience
• Cell Biology
• Pathophysiology

Background:

• Traumatic brain injury (TBI) presents a significant global health challenge with substantial economic impact.
• The complex pathophysiology of TBI hinders effective treatment, necessitating deeper molecular understanding.
• Ferroptosis, an iron-dependent programmed cell death, is increasingly recognized for its potential role in TBI pathology.

Purpose of the Study:

• To elucidate the association between ferroptosis and traumatic brain injury (TBI).
• To review ferroptosis pathways in the acute and chronic phases of TBI.
• To explore potential therapeutic strategies targeting ferroptosis for TBI treatment.

Main Methods:

• Literature review of studies investigating ferroptosis in the context of TBI.
• Analysis of research on ferroptosis pathways and their involvement in TBI pathophysiology.
• Examination of preclinical and clinical evidence for ferroptosis-targeting therapies in TBI.

Main Results:

• Ferroptosis is implicated in the acute and chronic stages of TBI.
• Inhibition of ferroptosis has shown promise in mitigating TBI-induced damage.
• Understanding ferroptosis mechanisms provides insights into TBI progression.

Conclusions:

• Ferroptosis plays a critical role in TBI pathogenesis.
• Targeting ferroptosis pathways represents a promising therapeutic avenue for improving TBI outcomes.
• Further research is warranted to fully harness ferroptosis modulation for TBI treatment.